EULAR 2026 Daily Podcast Day 4c

Guselkumab Delivers Across the PsA Disease Spectrum: APEX Trial RA BRIDGE and RA BRANCH trials: Baricitinib and VTE Risk Improving Referrals for Inflammatory Arthritis" Combination Therapy: Off the Shelf Allogenic NK and Rituximab in Rheumatic Disease

Episode metadata supplied by the publisher feed · Published Jun 8, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

EULAR 2026 Daily Podcast Day 4c

0:00 24:54

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Rheumnow Podcast?

This episode is 24 minutes long.

When was this Rheumnow Podcast episode published?

This episode was published on June 8, 2026.

Can I download this Rheumnow Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!